Notable Analyst Rating Changes 8/28: AMLN, BT, JAS Upgraded; KO, CHL, GILD Downgraded
Tweet Send to a Friend
StreetInsider.com Notable Analyst Rating Changes:
UPGRADES:
Merrill Lynch upgrades Amylin Pharmaceuticals (Nasdaq: AMLN) from Neutral to Buy.
Goldman ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
UPGRADES:
Merrill Lynch upgrades Amylin Pharmaceuticals (Nasdaq: AMLN) from Neutral to Buy.
Goldman ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
